1-2 of 2
mitoxantrone
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Minimally myelosuppressive regimen for remission induction in pediatric AML: long-term results of an observational study

Clinical Trials & Observations
Yixin Hu, Aili Chen, Li Gao, Hailong He, Shuting Jiang, Xinchang Zheng, Peifang Xiao, Jun Lu, Yi Wang, Jie Li, Jianqin Li, Junjie Fan, Yanhua Yao, Jing Ling, Liyan Fan, Shengqin Cheng, Cheng Cheng, Fang Fang, Jian Pan, Qian-fei Wang, Raul C. Ribeiro, Shaoyan Hu
Journal: Blood Advances
Blood Adv (2021) 5 (7): 1837–1847.
DOI: https://doi.org/10.1182/bloodadvances.2020003453
Published: 2021
Includes: Supplemental data
Journal Articles

A phase 1 study of azacitidine with high-dose cytarabine and mitoxantrone in high-risk acute myeloid leukemia

Clinical Trials & Observations
Kirk E. Cahill, Yasmin H. Karimi, Theodore G. Karrison, Nitin Jain, Margaret Green, Howard Weiner, Noreen Fulton, Sabah Kadri, Lucy A. Godley, Andrew S. Artz, Hongtao Liu, Michael J. Thirman, Michelle M. Le Beau, Megan E. McNerney, Jeremy Segal, Richard A. Larson, Wendy Stock, Olatoyosi Odenike
Journal: Blood Advances
Blood Adv (2020) 4 (4): 599–606.
DOI: https://doi.org/10.1182/bloodadvances.2019000795
Published: 2020
Includes: Supplemental data